UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1463217
IRVING, TX
Position in VRTX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$6,178,327
+$718,929 QoQ
Shares Held
12,438
+1.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#437
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $15,880,894 across 17 Biotechnology names. VRTX ranks #1 (38.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
12,438 | $6,178,327 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,651 | $1,653,004 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,155 | $1,250,779 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
13,677 | $1,070,498 | |
| 5 | MRNA |
Moderna, Inc.
|
13,077 | $915,782 | |
| 6 | CBUS |
Cibus, Inc.
|
576,043 | $789,178 | |
| 7 | INCY |
Incyte Corp
|
6,876 | $779,463 | |
| 8 | IMMX |
Immix Biopharma, Inc.
|
70,682 | $728,731 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,178,327 | 12,438 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $5,459,398 | 12,226 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,475,228 | 12,077 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,508,559 | 11,512 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,841,914 | 13,122 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $5,801,356 | 11,966 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,576,282 | 11,364 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,294,935 | 11,385 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,861,563 | 10,372 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,272,480 | 10,221 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,077,851 | 10,022 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,985,347 | 8,585 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,086,250 | 8,770 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,811,054 | 8,922 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $2,864,697 | 9,920 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $2,933,329 | 10,131 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,320,186 | 4,685 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $325,168 | 1,246 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $329,839 | 1,502 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $263,741 | 1,454 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $408,099 | 2,024 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $514,661 | 2,395 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $717,291 | 3,035 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $6,612,243 | 24,299 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,082,693 | 24,397 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,890,110 | 20,551 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||